AST
Asterias Biotherapeutics, Inc.
A biotech firm that turned human embryonic stem cells into therapies for repairing damaged nerves, most famously a treatment for spinal cord injuries. It was born in 2012 as BioTime Acquisition Corporation, a vehicle set up by BioTime to buy stem-cell programs from Geron, and renamed itself Asterias in 2013. The name comes from the starfish genus Asterias — a fitting nod to a creature famous for regrowing its own limbs.
CUSIP: 04624N107HealthcareUS1 holder
Total Value
$478.0K
Total Shares
147.8K
Net Share Change
+147.8K
Activity
1 buying
Investor
Value
Shares
Weight
Change
